253 related articles for article (PubMed ID: 32686305)
21. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
Pappo AS; Lyden E; Breitfeld P; Donaldson SS; Wiener E; Parham D; Crews KR; Houghton P; Meyer WH;
J Clin Oncol; 2007 Feb; 25(4):362-9. PubMed ID: 17264331
[TBL] [Abstract][Full Text] [Related]
22. Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience.
Saab R; Khoury JD; Krasin M; Davidoff AM; Navid F
Pediatr Blood Cancer; 2007 Sep; 49(3):274-9. PubMed ID: 16685737
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy in patients with refractory Ewing sarcoma].
Raciborska A; Bilska K; Drabko K; Rogowska E; Chaber R; Pogorzała M; Wyrobek E; Połczyńska K; Rodriguez-Galindo C; Woźniak W
Med Wieku Rozwoj; 2013; 17(2):117-25. PubMed ID: 23988368
[TBL] [Abstract][Full Text] [Related]
24. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
[TBL] [Abstract][Full Text] [Related]
25. Desmoplastic small round cell tumour in children and adolescents.
Bisogno G; Roganovich J; Sotti G; Ninfo V; di Montezemolo LC; Donfrancesco A; Mascarin M; Carli M
Med Pediatr Oncol; 2000 May; 34(5):338-42. PubMed ID: 10797355
[TBL] [Abstract][Full Text] [Related]
26. Desmoplastic small round cell tumor: from state of the art to future clinical prospects.
Hovsepyan S; Giani C; Pasquali S; Di Giannatale A; Chiaravalli S; Colombo C; Orbach D; Bergamaschi L; Vennarini S; Gatz SA; Gasparini P; Berlanga P; Casanova M; Ferrari A
Expert Rev Anticancer Ther; 2023 May; 23(5):471-484. PubMed ID: 37017324
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma.
Dogan I; Iribas A; Ahmed MA; Basaran M
J Chemother; 2023 Jul; 35(4):343-347. PubMed ID: 35894948
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of the diagnosis and treatment of desmoplastic small round cell tumor].
Lu B; Zhang W; Shang Z; Sun E; Nian X; Gao J; Ma C; Han R
Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):686-90. PubMed ID: 26813434
[TBL] [Abstract][Full Text] [Related]
29. Desmoplastic Small Round-cell Tumor: Retrospective Review of Institutional Data and Literature Review.
Jayakrishnan T; Moll R; Sandhu A; Sanguino A; Kaur G; Mao S
Anticancer Res; 2021 Aug; 41(8):3859-3866. PubMed ID: 34281846
[TBL] [Abstract][Full Text] [Related]
30. Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors.
Wagner L; Turpin B; Nagarajan R; Weiss B; Cripe T; Geller J
Pediatr Blood Cancer; 2013 Sep; 60(9):1447-51. PubMed ID: 23630159
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy combined with apatinib for the treatment of desmoplastic small round cell tumors: A case report.
Tian Y; Cheng X; Li Y
J Cancer Res Ther; 2020 Sep; 16(5):1177-1181. PubMed ID: 33004767
[TBL] [Abstract][Full Text] [Related]
32. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Thompson PA; Malogolowkin MH; Furman WL; Piao J; Krailo MD; Chung N; Brock L; Towbin AJ; McCarville EB; Finegold MJ; Ranganathan S; Dunn SP; Langham MR; McGahren ED; Tiao GM; Weldon CB; O'Neill AF; Rodriguez-Galindo C; Meyers RL; Katzenstein HM
Pediatr Blood Cancer; 2023 Jul; 70(7):e30365. PubMed ID: 37073741
[TBL] [Abstract][Full Text] [Related]
33. Multiagent chemotherapy including IrIVA regimen and maintenance therapy in the treatment of desmoplastic small round cell tumor.
Ferrari A; Bergamaschi L; Chiaravalli S; Pecori E; Diletto B; Alessandro O; Giandini T; Livellara V; Sironi G; Casanova M
Tumori; 2022 Feb; 108(1):93-97. PubMed ID: 33594944
[TBL] [Abstract][Full Text] [Related]
34. Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors.
Mascarenhas L; Ogawa C; Laetsch TW; Weigel BJ; Bishop MW; Krystal J; Borinstein SC; Slotkin EK; Muscal JA; Hingorani P; Levy DE; Mo G; Shahir A; Wright J; DuBois SG
Cancer Med; 2021 Feb; 10(3):843-856. PubMed ID: 33474828
[TBL] [Abstract][Full Text] [Related]
35. Desmoplastic small round cell tumors: Multimodality treatment and new risk factors.
Scheer M; Vokuhl C; Blank B; Hallmen E; von Kalle T; Münter M; Wessalowski R; Hartwig M; Sparber-Sauer M; Schlegel PG; Kramm CM; Kontny U; Spriewald B; Kegel T; Bauer S; Kazanowska B; Niggli F; Ladenstein R; Ljungman G; Jahnukainen K; Fuchs J; Bielack SS; Klingebiel T; Koscielniak E;
Cancer Med; 2019 Feb; 8(2):527-542. PubMed ID: 30652419
[TBL] [Abstract][Full Text] [Related]
36. Anesthesia and Pain Management for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Desmoplastic Small Round Cell Tumors in Children, Adolescents, and Young Adults.
Anghelescu DL; Brown CL; Murphy AJ; Davidoff AM; Dickson PV; Glazer ES; Stiles ZE; Bishop MW; Douthitt L; Deneve JL
Ann Surg Oncol; 2019 Jan; 26(1):131-138. PubMed ID: 30353396
[TBL] [Abstract][Full Text] [Related]
37. [Irinotecan plus temozolomide in refractory or relapsed pediatric solid tumors].
Hernández-Marqués C; Lassaletta-Atienza A; Ruiz Hernández A; Blumenfeld Olivares JA; Arce Abaitua B; Cormenzana Carpio M; Madero Lopez L
An Pediatr (Barc); 2013 Aug; 79(2):68-74. PubMed ID: 23332825
[TBL] [Abstract][Full Text] [Related]
38. Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial.
Xu J; Xie L; Sun X; Liu K; Liang X; Cai Z; Tang X; Guo W
Clin Cancer Res; 2023 Mar; 29(6):1040-1046. PubMed ID: 36622702
[TBL] [Abstract][Full Text] [Related]
39. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
Mascarenhas L; Felgenhauer JL; Bond MC; Villaluna D; Femino JD; Laack NN; Ranganathan S; Meyer J; Womer RB; Gorlick R; Krailo MD; Marina N
Pediatr Blood Cancer; 2016 Mar; 63(3):493-8. PubMed ID: 26579879
[TBL] [Abstract][Full Text] [Related]
40. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]